GlassScriptPhysician profile
Brian Patrick Spearman
NPI 1295226652
$8,510.80
in general payments reported to CMS, 2019-2025
12 companies · $2,754 in 2025
The $2,754 reported for 2025 was more than what 79% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $222 · 2023: $1,747 · 2024: $3,788 · 2025: $2,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,878 · Food and Beverage: $3,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,878.30 |
| Food and Beverage | $3,410.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $3,721.02 | 2023-2025 | Azur Cx Detachable, Glidesheath Slender, Hydropearl |
| Inari Medical, INC. | $3,473.06 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $389.35 | 2022-2025 | Obsidio, Embold Fibered |
| Stryker Corporation | $333.19 | 2025 | Venacore Thrombectomy Catheter, Artix Mt |
| Smith+Nephew, INC. | $141.96 | 2024 | Pico, Renasys Go V2 Home |
| W. L. Gore & Associates, INC. | $101.60 | 2022 | |
| Bard Peripheral Vascular, INC. | $98.16 | 2023 | |
| Medtronic, INC. | $81.95 | 2025 | Concerto Versa |
| Becton, Dickinson and Company | $67.09 | 2025 | Powerpicc |
| Penumbra, INC. | $62.08 | 2025 | Penumbra System |
| Cardiva Medical, INC. | $24.44 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cook Medical LLC | $16.90 | 2024 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Spearman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.